Recent results of our research team showed that Orai1 is upregulated in glioma specimens and glioma cell lines compared with nontumor control brain tissue, and the regulatory degree is positively correlated with the grades of gliomas. This evidence concerns the gene ORAI1 and central nervous system cancer.